Comment on: Tenofovir DF/emtricitabine/rilpivirine as HIV post-exposure prophylaxis: results from a multicentre prospective study
- PMID: 31280307
- DOI: 10.1093/jac/dkz301
Comment on: Tenofovir DF/emtricitabine/rilpivirine as HIV post-exposure prophylaxis: results from a multicentre prospective study
Comment in
-
Tenofovir DF/emtricitabine/rilpivirine as HIV post-exposure prophylaxis: results from a multicentre prospective study-authors' response.J Antimicrob Chemother. 2019 Nov 1;74(11):3403-3404. doi: 10.1093/jac/dkz351. J Antimicrob Chemother. 2019. PMID: 31424548 No abstract available.
Comment on
-
Tenofovir DF/emtricitabine/rilpivirine as HIV post-exposure prophylaxis: results from a multicentre prospective study.J Antimicrob Chemother. 2019 Apr 1;74(4):1021-1027. doi: 10.1093/jac/dky547. J Antimicrob Chemother. 2019. PMID: 30689937
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
